Albumin BCG2 04U3020; Albumin BCG2 04U3030
Albania medical device registration · Abbott Ireland Diagnostic Division, Lisnamuck, Longford, Co.Longford , Ireland · Invitro · Model Albumin BCG2 04U3020 (1044 tests); Albumin BCG2 04U3030 (3120 tests) · Registered December 24, 2020
- Risk Class
- Invitro
- Product Model
- Albumin BCG2 04U3020 (1044 tests); Albumin BCG2 04U3030 (3120 tests)
- Product Name
- Albumin BCG2 04U3020; Albumin BCG2 04U3030
- Registration Date
- December 24, 2020
- Analysis ID
- 8615
Reagente te cilet perdoren per gjetjen sasiore te albumines ne serumin njerezor dhe ne plazem ne analizatoret Architect.
Access comprehensive regulatory information for Albumin BCG2 04U3020; Albumin BCG2 04U3030 in the Albania medical device market through Pure Global AI's free database. This Invitro medical device is manufactured by Abbott Ireland Diagnostic Division, Lisnamuck, Longford, Co.Longford , Ireland. The device was registered on December 24, 2020.
This page provides complete registration details including product model (Albumin BCG2 04U3020 (1044 tests); Albumin BCG2 04U3030 (3120 tests)), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.